Plain-English translation of NCT06850870 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a new rideshare service called Door-Through-Door (D2D) that pairs older adults and people with memory loss with trained companion drivers who help them get from their home directly to their medical appointment and back. Instead of standard rideshare where you're picked up and dropped off at the curb, this service focuses on helping people who may need extra support navigating the entire trip.
Many older adults and people with memory problems struggle to get to their medical appointments safely and independently, even when transportation is available. This trial wants to see if having a trained companion driver who helps throughout the entire journey—not just the car ride—makes it easier for people to keep their appointments and stay healthy.
You likely qualify if…
You likely don't qualify if…
If you are selected, you will be randomly assigned to either the new Door-Through-Door service with a trained companion driver, or to a standard rideshare service. You will use your assigned service for your scheduled medical appointments over the study period. Researchers will track how well each service works for you and ask about your experience using simple surveys or interviews.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States